Компания ТОМО 2020 совместно с компанией Accuray (USA) принимает активное участие в борьбе с раком молочной железы.

                       Over 2 million people worldwide will be diagnosed with breast cancer this year alone.1, 2   

View it in your browser.

 

For these women and men, there is nothing more powerful than confidence. Confidence that their treatment - and their treatment team - will help them beat breast cancer.

At Accuray, our legacy of patient-first innovation drives unique capabilities in the confident treatment of breast cancer. Capabilities which give clinicians greater confidence in their ability to deliver highly precise, highly personalized treatments - and capabilities which give patients confidence in a rapid return to life as usual, and a healthy future.

The Radixact®, TomoTherapy® and CyberKnife® Systems provide the flexibility to adapt radiation therapy to any breast cancer patient’s anatomy, delivering optimal coverage to the target volumes with minimized cardiac dose and organ-at-risk exposure. 

 

See How the Radixact® System Redefines
Personalized Breast Cancer Treatment

 

Breast IMRT with TomoHelical™
TomoHelical™ Treatment Delivery, Accuray’s flagship helical delivery mode available for the Radixact® and TomoTherapy® Systems, sets the gold standard for the treatment of complex breast tumors.
Breast 3D-CRT with TomoDirect™ The TomoDirect™ modality offers a highly efficient treatment option for routine indications, available for the Radixact and TomoTherapy Systems.


 
Hear How the CyberKnife® System Can Treat
Breast Cancer
 
VIEW THE WEBINAR
CyberKnife® System Experience for Partial Breast Irradiation
Presented by Asal Rahimi, MD, MS – U.T. Southwestern Medical Center,
Dallas, TX.
  

LEARN MORE ABOUT THE CLINICAL ADVANTAGES OF ACCURAY TECHNOLOGIES